山东大学耳鼻喉眼学报 ›› 2023, Vol. 37 ›› Issue (6): 1-5.doi: 10.6040/j.issn.1673-3770.0.2023.184

• 述评 •    下一篇

阻塞性睡眠呼吸暂停合并症的研究现状和未来展望

任晓勇   

  1. 西安交通大学第二附属医院 耳鼻咽喉头颈外科, 陕西 西安 710004
  • 发布日期:2023-12-15
  • 通讯作者: 任晓勇. E-mail:renxiaoyong@vip.sina.com
  • 基金资助:
    国家自然科学基金项目(62076198)

Current status and future perspectives of research on obstructive sleep apnea comorbidities

REN Xiaoyong   

  1. Department of Otorhinolaryngology & Head and Neck Surgery, The Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an 710004, Shaanxi, China
  • Published:2023-12-15

摘要: 阻塞性睡眠呼吸暂停(obstructive sleep apnea, OSA)是最常见的睡眠呼吸障碍疾病,在人群中患病率高,危害广泛。OSA的疾病进展可能引起神经、心血管、内分泌等多系统损害,且OSA与上述合并症彼此影响相互促进,终致严重不良后果。重视OSA与多系统合并症的关系,开展多学科协作诊疗,提供高质量、精准化、个体化诊疗方案成为当今关注的热点。论文将就OSA及其神经认知损伤、心脑血管疾病、内分泌疾病及头颈部肿瘤等常见合并症的研究进展和未来方向进行了简要的叙述和探讨,以期提升对OSA及其合并症的科学认知,为OSA多学科协作诊疗提供思路。

关键词: 阻塞性睡眠呼吸暂停, 神经认知损伤, 心脑血管疾病, 内分泌疾病, 头颈部肿瘤

Abstract: Obstructive sleep apnea(OSA)is the most common sleep-related breathing disorder, with a high prevalence that causes widespread harm in the population. As OSA progresses, it may damage multiple systems, such as the nervous, cardiovascular, and endocrine systems. OSA and these comorbidities influence and promote each other, and eventually lead to serious adverse consequences. Therefore, emphasizing the relationship between OSA and multi-system comorbidities, carrying out multi-disciplinary team diagnosis and treatment, and providing high-quality, precise, and individualized diagnosis and treatment programs are current research hotspots. This article provides a brief description and discussion of the progress and future direction of research on OSA and its common comorbidities, such as neurocognitive impairment, cardiovascular and cerebrovascular disease, endocrine disease, and head and neck carcinoma. This paper aims to improve our understanding of OSA and its comorbidities and provide ideas for multidisciplinary collaborative diagnosis and treatment of OSA.

Key words: Obstructive sleep apnea, Neurocognitive impairment, Cardiovascular and cerebrovascular disease, Endocrine disease, Head and neck carcinoma

中图分类号: 

  • R766
[1] Gottlieb DJ, Punjabi NM. Diagnosis and management of obstructive sleep apnea: a review[J]. JAMA, 2020, 323(14): 1389-1400. doi:10.1001/jama.2020.3514
[2] Benjafield AV, Ayas NT, Eastwood PR, et al. Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis[J]. Lancet Respir Med, 2019, 7(8): 687-698. doi:10.1016/S2213-2600(19)30198-5
[3] Young T, Peppard PE, Gottlieb DJ. Epidemiology of obstructive sleep apnea: a population health perspective[J]. Am J Respir Crit Care Med, 2002, 165(9): 1217-1239. doi:10.1164/rccm.2109080
[4] Palm A, Theorell-Haglöw J, Isakson J, et al. Association between obstructive sleep apnoea and cancer: a cross-sectional, population-based study of the DISCOVERY cohort[J]. BMJ Open, 2023, 13(3): e064501. doi:10.1136/bmjopen-2022-064501
[5] Li JX, Yan WJ, Yi MH, et al. Efficacy of CPAP duration and adherence for cognitive improvement in patients with obstructive sleep apnea: a meta-analysis of randomized controlled trials[J]. Schlaf Atmung, 2023, 27(3): 973-982. doi:10.1007/s11325-022-02687-y
[6] Lal C, Ayappa I, Ayas N, et al. The link between obstructive sleep apnea and neurocognitive impairment: an official American thoracic society workshop report[J]. Ann Am Thorac Soc, 2022, 19(8): 1245-1256. doi:10.1513/AnnalsATS.202205-380ST
[7] Naismith SL, Duffy SL, Cross N, et al. Nocturnal hypoxemia is associated with altered parahippocampal functional brain connectivity in older adults at risk for dementia[J]. J Alzheimers Dis, 2020, 73(2): 571-584. doi:10.3233/JAD-190747
[8] Vanek J, Prasko J, Genzor S, et al. Obstructive sleep apnea, depression and cognitive impairment[J]. Sleep Med, 2020, 72: 50-58. doi:10.1016/j.sleep.2020.03.017
[9] Zhang PP, Wang YH, Wang HY, et al. Sesamol alleviates chronic intermittent hypoxia-induced cognitive deficits via inhibiting oxidative stress and inflammation in rats[J]. Neuroreport, 2021, 32(2): 105-111. doi:10.1097/WNR.0000000000001564
[10] Salminen A, Kauppinen A, Kaarniranta K. Hypoxia/ischemia activate processing of Amyloid Precursor Protein: impact of vascular dysfunction in the pathogenesis of Alzheimer's disease[J]. J Neurochem, 2017, 140(4): 536-549. doi:10.1111/jnc.13932
[11] She NN, Shi YW, Feng YN, et al. NLRP3 inflammasome regulates astrocyte transformation in brain injury induced by chronic intermittent hypoxia[J]. BMC Neurosci, 2022, 23(1): 70. doi:10.1186/s12868-022-00756-2
[12] Puech C, Badran M, Runion AR, et al. Cognitive impairments, neuroinflammation and blood-brain barrier permeability in mice exposed to chronic sleep fragmentation during the daylight period[J]. Int J Mol Sci, 2023, 24(12): 9880. doi:10.3390/ijms24129880
[13] Shobatake R, Ota H, Takahashi N, et al. The impact of intermittent hypoxia on metabolism and cognition[J]. Int J Mol Sci, 2022, 23(21): 12957. doi:10.3390/ijms232112957
[14] Kerner NA, Roose SP, Pelton GH, et al. Association of obstructive sleep apnea with episodic memory and cerebral microvascular pathology: a preliminary study[J]. Am J Geriatr Psychiatry, 2017, 25(3): 316-325. doi:10.1016/j.jagp.2016.11.009
[15] Shah NA, Yaggi HK, Concato J, et al. Obstructive sleep apnea as a risk factor for coronary events or cardiovascular death[J]. Schlaf Atmung, 2010, 14(2): 131-136. doi:10.1007/s11325-009-0298-7
[16] Yeghiazarians Y, Jneid H, Tietjens JR, et al. Obstructive sleep apnea and cardiovascular disease: a scientific statement from the American heart association[J]. Circulation, 2021, 144(3): e56-e67. doi:10.1161/CIR.0000000000000988
[17] 张慧, 吕慧霞. 阻塞性睡眠呼吸暂停在心衰进展中的作用机制及其治疗研究进展[J]. 山东大学耳鼻喉眼学报, 2023, 37(6): 33-40. doi: 10.6040/j.issn. 1673-3770.0.2022.051 ZHANG Hui, LÜ Huixia. Research progress in mechanism and treatment of obstructive sleep apnea in heart failure[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(6): 33-40. doi: 10.6040/j.issn. 1673-3770.0.2022.051
[18] Logan AG, Perlikowski SM, Mente A, et al. High prevalence of unrecognized sleep apnoea in drug-resistant hypertension[J]. J Hypertens, 2001, 19(12): 2271-2277. doi:10.1097/00004872-200112000-00022
[19] Somers VK, White DP, Amin R, et al. Sleep apnea and cardiovascular disease: an American heart association/american college of cardiology foundation scientific statement from the American heart association council for high blood pressure research professional education committee, council on clinical cardiology, stroke council, and council on cardiovascular nursing. in collaboration with the national heart, lung, and blood institute national center on sleep disorders research(national institutes of health)[J]. Circulation, 2008, 118(10): 1080-1111. doi:10.1161/CIRCULATIONAHA.107.189375
[20] Albuquerque FN, Calvin AD, Sert Kuniyoshi FH, et al. Sleep-disordered breathing and excessive daytime sleepiness in patients with atrial fibrillation[J]. Chest, 2012, 141(4): 967-973. doi:10.1378/chest.11-0975
[21] Seiler A, Camilo M, Korostovtseva L, et al. Prevalence of sleep-disordered breathing after stroke and TIA: a meta-analysis[J]. Neurology, 2019, 92(7): e648-e654. doi:10.1212/WNL.0000000000006904
[22] Ryan S. Mechanisms of cardiovascular disease in obstructive sleep apnoea[J]. J Thorac Dis, 2018, 10(Suppl 34): S4201-S4211. doi:10.21037/jtd.2018.08.56
[23] Orrù G, Storari M, Scano A, et al. Obstructive Sleep Apnea, oxidative stress, inflammation and endothelial dysfunction-An overview of predictive laboratory biomarkers[J]. Eur Rev Med Pharmacol Sci, 2020, 24(12): 6939-6948. doi:10.26355/eurrev_202006_21685
[24] Green M, Ken-Dror G, Fluck D, et al. Meta-analysis of changes in the levels of catecholamines and blood pressure with continuous positive airway pressure therapy in obstructive sleep apnea[J]. J Clin Hypertens, 2021, 23(1): 12-20. doi:10.1111/jch.14061
[25] Fang SC, Wu YL, Tsai PS. Heart rate variability and risk of all-cause death and cardiovascular events in patients with cardiovascular disease: a meta-analysis of cohort studies[J]. Biol Res Nurs, 2020, 22(1): 45-56. doi:10.1177/1099800419877442
[26] Patel N, Donahue C, Shenoy A, et al. Obstructive sleep apnea and arrhythmia: a systemic review[J]. Int J Cardiol, 2017, 228: 967-970. doi:10.1016/j.ijcard.2016.11.137
[27] Bambhroliya Z, Sandrugu J, Lowe M, et al. Diabetes, polycystic ovarian syndrome, obstructive sleep apnea, and obesity: a systematic review and important emerging themes[J]. Cureus, 2022, 14(6): e26325. doi:10.7759/cureus.26325
[28] Lanfranco F, Motta G, Minetto MA, et al. Growth hormone/insulin-like growth factor-I axis in obstructive sleep apnea syndrome: an update[J]. J Endocrinol Invest, 2010, 33(3): 192-196. doi:10.1007/BF03346580
[29] Sharma R, Sharma BB, Sharma R, et al. Obesity, thyroid and OSA: an intriguing triangle[J]. J Assoc Physicians India, 2022, 70(4): 11-12
[30] Bozkurt NC, Karbek B, Cakal E, et al. The association between severity of obstructive sleep apnea and prevalence of Hashimoto's thyroiditis[J]. Endocr J, 2012, 59(11): 981-988. doi:10.1507/endocrj.ej12-0106
[31] Shi YW, Cao Z, Xie YS, et al. Association between obstructive sleep apnea and thyroid function: a 10-year retrospective study[J]. Sleep Med, 2023, 103: 106-115. doi:10.1016/j.sleep.2023.01.027
[32] Aslan M, Cosar N, Celik H, et al. Evaluation of oxidative status in patients with hyperthyroidism[J]. Endocrine, 2011, 40(2): 285-289. doi:10.1007/s12020-011-9472-3
[33] Mayer L, Romi c Z, Skreb F, et al. Antioxidants in patients with hyperthyroidism[J]. Clin Chem Lab Med, 2004, 42(2): 154-158. doi:10.1515/CCLM.2004.028
[34] Barreiro Arcos ML. Role of thyroid hormones-induced oxidative stress on cardiovascular physiology[J]. Biochim Biophys Acta Gen Subj, 2022, 1866(12): 130239. doi:10.1016/j.bbagen.2022.130239
[35] Weng CL, Huang L, Feng HW, et al. Gestational chronic intermittent hypoxia induces hypertension, proteinuria, and fetal growth restriction in mice[J]. Schlaf Atmung, 2022, 26(4): 1661-1669. doi:10.1007/s11325-021-02529-3
[36] Eggo MC, Quiney VM, Campbell S. Local factors regulating growth and function of human thyroid cells in vitro and in vivo[J]. Mol Cell Endocrinol, 2003, 213(1): 47-58. doi:10.1016/j.mce.2003.10.034
[37] Sorensen JR, Winther KH, Bonnema SJ, et al. Respiratory manifestations of hypothyroidism: a systematic review[J]. Thyroid, 2016, 26(11): 1519-1527. doi:10.1089/thy.2015.0642
[38] Green ME, Bernet V, Cheung J. Thyroid dysfunction and sleep disorders[J]. Front Endocrinol, 2021, 12: 725829. doi:10.3389/fendo.2021.725829
[39] Bruyneel M, Veltri F, Poppe K. Prevalence of newly established thyroid disorders in patients with moderate-to-severe obstructive sleep apnea syndrome[J]. Schlaf Atmung, 2019, 23(2): 567-573. doi:10.1007/s11325-018-1746-z
[40] Jara SM, Phipps AI, Maynard C, et al. The association of sleep apnea and cancer in veterans[J]. Otolaryngol Head Neck Surg, 2020, 162(4): 581-588. doi:10.1177/0194599819900487
[41] Choi JH, Lee JY, Lim YC, et al. Association between obstructive sleep apnea and thyroid cancer incidence: a national health insurance data study[J]. Eur Arch Otorhinolaryngol, 2021, 278(11): 4569-4574. doi:10.1007/s00405-021-06896-1
[42] Mulla O, Agada F, Dawson D, et al. Deep lobe parotid pleomorphic adenoma presenting as obstructive sleep apnoea[J]. BMJ Case Rep, 2013, 2013: bcr2013008655. doi:10.1136/bcr-2013-008655
[43] Gozal D, Almendros I, Phipps AI, et al. Sleep apnoea adverse effects on cancer: true, false, or too many confounders?[J]. Int J Mol Sci, 2020, 21(22): 8779. doi:10.3390/ijms21228779
[44] Wei JF, Hu ML, Du HL. Improving cancer immunotherapy: exploring and targeting metabolism in hypoxia microenvironment[J]. Front Immunol, 2022, 13: 845923. doi:10.3389/fimmu.2022.845923
[45] Ravi R, Mookerjee B, Bhujwalla ZM, et al. Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha[J]. Genes Dev, 2000, 14(1): 34-44
[46] Liu YN, Yang JF, Huang DJ, et al. Hypoxia induces mitochondrial defect that promotes T cell exhaustion in tumor microenvironment through MYC-regulated pathways[J]. Front Immunol, 2020, 11: 1906. doi:10.3389/fimmu.2020.01906
[47] Xi L, Peng MX, Liu SQ, et al. Hypoxia-stimulated ATM activation regulates autophagy-associated exosome release from cancer-associated fibroblasts to promote cancer cell invasion[J]. J Extracell Vesicles, 2021, 10(11): e12146. doi:10.1002/jev2.12146
[48] Lira AB, de Sousa Rodrigues CF. Evaluation of oxidative stress markers in obstructive sleep apnea syndrome and additional antioxidant therapy: a review article[J]. Sleep Breath, 2016, 20(4): 1155-1160. doi:10.1007/s11325-016-1367-3
[49] Sethi G, Shanmugam MK, Ramachandran L, et al. Multifaceted link between cancer and inflammation[J]. Biosci Rep, 2012, 32(1): 1-15. doi:10.1042/BSR20100136
[1] 熊琴, 张砚, 乌日娜, 李锋, 唐力行. 鼻用糖皮质激素在儿童中的应用[J]. 山东大学耳鼻喉眼学报, 2025, 39(6): 160-167.
[2] 卫志成,彭裕,沈力,李莉琳,沈杭东,李馨仪,许华俊,关建. 犬尿氨酸介导阻塞性睡眠呼吸暂停所致肝功能损伤:一项横断面研究[J]. 山东大学耳鼻喉眼学报, 2025, 39(3): 38-44.
[3] 马馨,董凌康,吴红敏,易红良,邹建银. 外展悬吊缝合技术在阻塞性睡眠呼吸暂停治疗中的改良及应用进展[J]. 山东大学耳鼻喉眼学报, 2025, 39(3): 81-88.
[4] 李莉琳,李馨仪,关建. 阻塞性睡眠呼吸暂停与抑郁症共病机制的研究进展[J]. 山东大学耳鼻喉眼学报, 2025, 39(3): 89-96.
[5] 杨鸣,刘雪霞,张华. m6A识别蛋白IGF2BPs家族在头颈肿瘤中的研究进展[J]. 山东大学耳鼻喉眼学报, 2025, 39(3): 153-161.
[6] 黄佳丽,刘梓琪,徐娟,陈曦,张立庆,周涵. 咽部梭形细胞鳞状细胞癌的临床及预后分析[J]. 山东大学耳鼻喉眼学报, 2025, 39(2): 94-100.
[7] 王小清,王钰彧,仇金玮,许金侠,朱梅. 口面肌功能训练对鼾声患者鼾声指标及睡眠质量的影响[J]. 山东大学耳鼻喉眼学报, 2025, 39(2): 101-107.
[8] 刘莲莲,李进让. 阻塞性睡眠呼吸暂停与咽喉反流[J]. 山东大学耳鼻喉眼学报, 2024, 38(6): 15-22.
[9] 罗露,周恩,肖旭平,林志强,方志杰,吕晓虹. 等离子点状激发技术在儿童OSA扁桃体腺样体切除术联合围手术期快速康复中的应用[J]. 山东大学耳鼻喉眼学报, 2024, 38(5): 26-30.
[10] 张静祎,董湘依,牟亚魁,宋西成. 细胞焦亡在耳鼻咽喉科疾病中的研究进展[J]. 山东大学耳鼻喉眼学报, 2024, 38(4): 140-148.
[11] 赵云,滕支盼,李琦,沈小飞. 儿童腺样体扁桃体切除后圆枕增生26例[J]. 山东大学耳鼻喉眼学报, 2024, 38(3): 43-48.
[12] 王桂芳,李仁高,马青. H-UPPP联合低温等离子舌根射频消融术对OSAHS患者血氧饱和度及动脉血氧分压的影响[J]. 山东大学耳鼻喉眼学报, 2024, 38(3): 49-54.
[13] 胡婷婷,王越华. 阻塞性睡眠呼吸暂停与乳腺癌相关性研究进展[J]. 山东大学耳鼻喉眼学报, 2023, 37(6): 41-45.
[14] 朱雅欣,刘峰,关建,殷善开. 儿童扁桃体腺样体肥大组织淋巴细胞改变的研究进展[J]. 山东大学耳鼻喉眼学报, 2023, 37(6): 62-67.
[15] 王璐,张云云,郭华,崔小川. 脂质代谢标志物在早期筛查阻塞性睡眠呼吸暂停患者中阿尔兹海默症的应用价值[J]. 山东大学耳鼻喉眼学报, 2023, 37(6): 68-74.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!